amfAR, The Foundation for AIDS Research
amfAR returned to Cap d’Antibes, May 23, for a record-breaking twentieth edition of its celebrated Cinema Against AIDS benefit.
New report provides first ever comprehensive analysis of financing and implementation of HIV programs for gay men, other men who have sex with men (MSM) and transgender individuals in Southern Africa.
A decade ago, almost nobody spoke of curing HIV infection as a realistic goal, yet we find ourselves in early 2013 with not one, nor even two, but three different types of HIV cure.
Our infographic illustrates the stark differences in the human impact of the House, Senate and White House global AIDS funding proposals for fiscal year 2014.
New amfAR film documents in very human terms the public health and economic benefits of syringe services programs.
amfAR grantee Dr. Sarah Palmer is at the forefront of the search for ultrasensitive methods of detecting minuscule amounts of HIV.
The persistent shortchanging of PEPFAR is one of the more significant and perplexing trends in America's global health policy.
amfAR grantees Dr. Deborah Persaud of Johns Hopkins Children's Center and Dr. Katherine Luzuriaga of the University of Massachusetts Medical School, along with Dr. Hannah Gay of the University of Mississippi, have been included in the 2013 TIME 100.
If you missed it on May 23, you can still catch the dazzling runway action at the Cinema Agains AIDS "Ultimate Gold Collection Fashion Show," curated by Carine Roitfeld.
To find out more about the GMT Initiative application process select your language below.